Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, our pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
| Website | http://www.parsebiosciences.com |
| Revenue | $15.6 million |
| Employees | 133 (98 on RocketReach) |
| Founded | 2018 |
| Address | 700 Dexter Ave N Suite 600, Seattle, Washington 98109, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Single Cell Sequencing, Spatial Genomics, Next Generation Sequencing, Ngs, Gene Expression, Transcriptomics, Genomics, Proteomics, Biotechnology, Life Sciences, Molecular Biology, Cell Biology, Research Tools, Scientific Research, Healthcare, Drug Discovery, Biomedical Research, Personalized Medicine, Diagnostic Tools |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Cytiva, Bio-Rad Laboratories, 10x Genomics, PacBio, Bionano Genomics, Inc., Mission Bio, Zymergen, Inc. +43 more (view full list) |
Looking for a particular Parse Biosciences employee's phone or email?
The Parse Biosciences annual revenue was $15.6 million in 2026.
Charles Roco is the Co-Founder and CTO of Parse Biosciences.
98 people are employed at Parse Biosciences.
Parse Biosciences is based in Seattle, Washington.